ClinicalTrials.gg
RecruitingNCT05570136STEPUpdated Feb 7, 2024

Functional Exercise for Sarcopenia

An interventional study of Functional Exercise and Education in Sarcopenia, sponsored by Chang Gung Memorial Hospital. Recruiting at 7 sites in Taiwan. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2024-02-07.

Sponsored by Chang Gung Memorial Hospital · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Oct 2025, 1 year ago, but the record still lists the study as recruiting.
  • Started Oct 2022; still recruiting 4 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 14 studies in Sarcopenia by Chang Gung Memorial Hospital — 8 open to participants now, 8 under way, none of them phase 3. Sarcopenia · Chang Gung Memorial Hospital.

Planned enrollment
8th of 11
60 · median 90
Started
2022
with 2 others
No phase
11 of 14
7 open now
Registered
7th of 14
by date

Among the 14 studies in Sarcopenia by Chang Gung Memorial Hospital, this one is the 8th largest by planned enrollment of the 11 interventional ones that give a count, is one of 3 that started in 2022, is one of 11 with no phase, and was the 7th registered.

Sarcopenia

1,334 studies on the registry are indexed under Sarcopenia; 418 are open to participants now.

Browse Sarcopenia studies →

Open to participants now

8 of the 14 studies in Sarcopenia by Chang Gung Memorial Hospital are open now, in 1 country. Recruiting first, the newest first:

2 more — sign in →

By country, each count listing its studies:

All 8 open studies →

Where they have run

Who these studies take

Of the 246 Sarcopenia studies recruiting now, 155 (63%) set no upper age limit and 32 (13%) stop at 75 or younger; 9 take children under 18; 62 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 14 studies in Sarcopenia by Chang Gung Memorial Hospital, or all of them as a file.
02

Study summary

Sarcopenia is one of the major causes of functional decline and negative health outcomes among older adults. Prominent evidence suggests exercise interventions can reverse sarcopenia. However, past studies mainly focus on structured exercise programs, automatically excluding many older adults who are not motivated and lack the time/resources to conduct the structural exercise. Therefore, we propose to examine the effect of the Sarcopenia Translation functional Exercise Program (the STEP program) on community-dwelling older adults. The STEP is a functional exercise program designed to address low motivation and other time/resources barriers for rapid translation in community settings. The 12-week STEP program teaches older adults to apply functional exercise activities incorporating resistant training principles in their daily routines.

With a dual focus apriori in assessing clinical effectiveness and potential implementation strategies for future community implementations, we will conduct a single-blind randomized control trial among 60 community-dwelling older adults at risk or with sarcopenia. The study's purposes are threefold: (1) to assess the effect of the functional exercise intervention compared to usual care on primary outcomes of sarcopenia (muscle strength, muscle mass, and physical function); (2) to assess the long-term effects of the functional exercise intervention on primary outcomes of sarcopenia; (3) explore potential implementation strategies for rapid community implementation including development of a communityappropriate protocol for tracking long-term effects such as metabolomic biomarkers. This study aims to develop an effective functional exercise program as an alternative to structured exercise programs. Additionally, the goal is to accelerate the translation of the functional exercise program for older adults at risk or with sarcopenia in real-world settings.

03

Conditions studied

  • Sarcopenia

Browse trials for

Keywords

  • habit
  • community
  • older adult
  • functional exercise
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. age 65 or older
  2. reside in northern Taiwan
  3. at risk of /with sarcopenia determined by AWGS diagnostic guidelines

Exclusion criteria

Exclusion Criteria:

  1. meets physical activity guidelines for older adults: conduct at least 150 minutes of moderate-intensity activity or 75 minutes of vigorous-intensity activity weekly
  2. needs 24-hour resistance for the activity of daily living activities
  3. has severe knee or back pain
  4. severely impaired mobility or wheelchair bounded (ruling out possible secondary sarcopenia patients)
  5. unstable cardiac conditions such as ventricular dysrhythmias, pulmonary edema, or other musculoskeletal conditions
  6. impaired cognition ( [MMSE] score \< 24, or \<17 for participants with lower education level)
  7. has a metal clip, implant, or pacemaker
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Treatment

    Participants in the treatment group will receive the 12-week STEP by a trained interventionist. In the first four weeks, the interventionist will focus on building participants' selfefficacy and health literacy and help participants learn the STEP exercise and principles. In the following four weeks, the interventionist will help the older adults to be more independent in prescribing exercise activities for themselves. In the last four weeks, participants will be fulling knowledgeable and independent on functional exercising; the interventionist will allocate community resources for long-term maintenance. After program completion, trained raters will administer at post-tests. There will also be a 3-month and 6-month follow-up evaluation after program completion.

    Behavioral: Functional Exercise

  • Sham comparator
    Control

    Participants in the control group will receive weekly health newsletters and will not get any suggestions or encouragement to do exercise from the research team. A staff member will call the control group participants weekly to document any new exercise programs from usual community services. At this stage, participants will not be excluded from the study if they join an exercise program, but we will document what kind of exercise they are conducting. Trained raters will administer at post-tests and two follow-ups.

    Behavioral: Education

Interventions

  • BehavioralFunctional Exercise

    Treatment group will receive the 12-week STEP by a trained interventionist. During the intervention period, an occupational therapist will help the participant to learn the STEP exercise and principles and help the older adults to be more independent on functional exercising.

  • BehavioralEducation

    In the education group, participant will receive weekly health newsletters containing general health aging materials. A staff member will call the control group participants weekly to document any new exercise programs from usual community services.

06

What researchers measure

Primary outcomes

  1. Change of skeletal muscle strength in 12 weeks and 3 and 6 month follow-ups

    Using a handheld dynamometer (MicroFET2, MMT) to measure the maximal isometric knee strength of the dominant leg with a standardized protocol.

    Time frame: From baseline to 6 month follow-up

  2. Change of muscle mass in 12 weeks and 3 and 6 month follow-ups

    Skeletal muscle mass will be measured by a portable Bio-impedance analysis (BIA) instrument at 50hz (Yida muscle mass and strength analyzer; YD01A), which had preliminary valid data for Taiwanese older adults and can be easily carried to community settings.

    Time frame: From baseline to 6 month follow-up

  3. Change of physical performance in 12 weeks and 3 and 6 month follow-ups

    The Short Physical Performance Battery (SPPB) is an assessment of lower extremity function with three subtests: (1) standing balance, (2) four-meter gait speed, and (3) five repetitions of sit-to-stand motion.

    Time frame: From baseline to 6 month follow-up

  4. The Reach, Adoption, Adherence and Fidelity of this research.

    Reach includes recruitment and retention rates. Adoption will be surveyed among participants and service networks at post-test. Adherence will be measured by the average number of activities recorded in the STEP activity planner. Fidelity is defined as treatment delivery, treatment receipt, and treatment enactment.

    Time frame: From baseline to 6 month follow-up

Secondary outcomes

  1. Change of exercise habit in 12 weeks and 3 and 6 month follow-ups

    Self-Reported Habit Index (SRHI), a self-rated assessment, which incorporates constructs such as habit strength, frequency, relevance to self-identity, and automaticity. Higher scores indicate that behavior is more strongly habitual.

    Time frame: From baseline to 6 month follow-up

  2. Change of sedentary time in 12 weeks and 3 and 6 month follow-ups

    Participants will wear an ActiGraph accelerometer over the right hip on an elasticized belt for seven days after the consent visit. Participants will be asked to wear the accelerometer throughout the day except swimming, showering, or bathing.

    Time frame: From baseline to 6 month follow-up

  3. Change of quality of life in 12 weeks and 3 and 6 month follow-ups

    The Chinese The World Health Organization Quality of Life-Brief assessment (WHOQoL-BREF) is a validated measure that assesses physical, psychological, social relationships, and environmental quality of life.

    Time frame: From baseline to 6 month follow-up

07

Study locations

1 of 7 sites recruiting
  • Pei Ai holistic care association
    New Taipei City, 242, Taiwan
    Active, not recruiting

    Not enrolling at this site.

  • Silver Care Association
    New Taipei City, Taiwan
    Active, not recruiting

    Not enrolling at this site.

  • Chinese e-touch community service association
    Taoyuan, Taiwan
    Active, not recruiting

    Not enrolling at this site.

  • Family Caregiver Care Association
    Taoyuan, Taiwan
    Active, not recruiting

    Not enrolling at this site.

  • Social Service Care Association (Guishan District)
    Taoyuan, Taiwan
    Active, not recruiting

    Not enrolling at this site.

  • Waishe community association
    Taoyuan, Taiwan
    Active, not recruiting

    Not enrolling at this site.

  • Zhongshan community association
    Taoyuan, Taiwan
    Recruiting
    • SHU-LING CHIU · Contact03-322-2617
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2022 (actual). Primary completion is estimated for Oct 2025, 36 months after the start.

Of 497 non-industry interventional studies with no phase under Sarcopenia, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 34. This study's planned 36 months is above that.

Counting every sponsor, half of 509 studies reached it within 18 months; a quarter within 8 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 4, 2022
First posted
Oct 6, 2022
StartActual
Oct 15, 2022
Primary completionEst.
Oct 30, 2025
CompletionEst.
Dec 30, 2025
Last update
Feb 7, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 7, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05570136
Responsible party
Yi-Ling Hu (Assistant Professor, Chang Gung Memorial Hospital) — Principal investigator
First posted
Oct 6, 2022
Start date
Oct 15, 2022
Primary completion
Oct 30, 2025 (estimated)
Completion
Dec 30, 2025 (estimated)
Last update
Feb 7, 2024

Study contacts

Yi-Ling Hu, Ph.D
Contact
huy@cgu.edu.tw
886-3-211-8800 ext. 3057
Jamie Hsu, BS
Contact
m1106203@cgu.edu.tw
886-3-211-8800 ext. 3057

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion